Ligand validation:4XP3

DX4: 2-amino-1,9-dihydro-6H-purine-6-thione

DX4 is a Ligand Of Interest in 4XP3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4XP3_DX4_A_401	73%	11%	0.124	0.951	2.55	1.67	3	2	0	0	100%	0.7818
4XOY_DX4_A_401	95%	10%	0.066	0.972	2.56	1.76	3	2	1	0	100%	1
3JQA_DX4_B_270	88%	9%	0.099	0.974	2.92	1.64	3	2	0	0	100%	1
4M5M_DX4_A_401	84%	33%	0.114	0.977	1.36	1.28	2	2	0	0	100%	1
3RKF_DX4_D_91	61%	11%	0.16	0.95	2.72	1.5	3	2	0	0	100%	1
5XU8_DX4_A_701	1%	7%	0.414	0.648	1.89	2.86	1	3	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.